These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 21750158

  • 1. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.
    Ford ML, Smith ER, Tomlinson LA, Chatterjee PK, Rajkumar C, Holt SG.
    Nephrol Dial Transplant; 2012 Feb; 27(2):727-33. PubMed ID: 21750158
    [Abstract] [Full Text] [Related]

  • 2. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG.
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [Abstract] [Full Text] [Related]

  • 3. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Suliman ME.
    J Nephrol; 2009 Feb; 22(6):774-82. PubMed ID: 19967657
    [Abstract] [Full Text] [Related]

  • 4. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M, Dahle DO, Mjøen G, Weihrauch G, Scharnagl H, Dobnig H, März W, Jardine A, Fellström B, Holdaas H.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M, Kalousová M, Kratochvílová M, Dusilová-Sulková S, Uhrová J, Bandúr S, Malbohan IM, Zima T, Tesar V.
    Kidney Blood Press Res; 2009 Jun; 32(4):276-83. PubMed ID: 19797911
    [Abstract] [Full Text] [Related]

  • 6. Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients.
    Sezer S, Karakan S, Ozdemir N.
    Ren Fail; 2012 Jun; 34(4):454-9. PubMed ID: 22320145
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of fibroblast growth factor-23 in children with chronic kidney disease.
    Magnusson P, Hansson S, Swolin-Eide D.
    Scand J Clin Lab Invest; 2010 Feb; 70(1):15-20. PubMed ID: 19929273
    [Abstract] [Full Text] [Related]

  • 8. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC, Tsai WC, Chen JY, Huang JJ.
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [Abstract] [Full Text] [Related]

  • 9. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [Abstract] [Full Text] [Related]

  • 10. Cardiac troponin T and end stage renal disease.
    Gabr AE, Ibrahim IA, Aloulou SM, Al-Alfi MA, Al-Abdlrahim KA.
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [Abstract] [Full Text] [Related]

  • 11. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
    Young A, Hodsman AB, Boudville N, Geddes C, Gill J, Goltzman D, Jassal SV, Klarenbach S, Knoll G, Muirhead N, Prasad GV, Treleaven D, Garg AX, Donor Nephrectomy Outcomes Research (DONOR) Network.
    Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
    [Abstract] [Full Text] [Related]

  • 12. Bone metabolism regulators and arterial stiffness in postmenopausal women.
    Albu A, Fodor D, Bondor C, Crăciun AM.
    Maturitas; 2013 Oct; 76(2):146-50. PubMed ID: 23916080
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG.
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [Abstract] [Full Text] [Related]

  • 14. Angiopoietin-2 levels predict mortality in CKD patients.
    David S, John SG, Jefferies HJ, Sigrist MK, Kümpers P, Kielstein JT, Haller H, McIntyre CW.
    Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
    [Abstract] [Full Text] [Related]

  • 15. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, Bonanno G, Fatuzzo P, Rapisarda F, Seminara G, Stancanelli B, Bellanuova I, Cataliotti A, Malatino LS.
    Am J Kidney Dis; 2002 Jul; 40(1):68-75. PubMed ID: 12087563
    [Abstract] [Full Text] [Related]

  • 16. Pulse pressure is an independent predictor of aortic stiffness in patients with mild to moderate chronic kidney disease.
    Stancanelli B, Malatino LS, Malaponte G, Noto P, Giuffrè E, Caruso A, Gagliano C, Zoccolo AM, Puccia G, Castellino P.
    Kidney Blood Press Res; 2007 Jul; 30(5):283-8. PubMed ID: 17622773
    [Abstract] [Full Text] [Related]

  • 17. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [Abstract] [Full Text] [Related]

  • 18. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.
    Edwards NC, Ferro CJ, Townend JN, Steeds RP.
    Heart; 2008 Aug; 94(8):1038-43. PubMed ID: 18308865
    [Abstract] [Full Text] [Related]

  • 19. Do cardiac troponins provide prognostic insight in hemodialysis patients?
    Choy JB, Armstrong PW, Ulan RA, Campbell PM, Gourishankar S, Prosser CI, Tymchak WJ.
    Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
    [Abstract] [Full Text] [Related]

  • 20. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients.
    Speer G, Fekete BC, El Hadj Othmane T, Szabó T, Egresits J, Fodor E, Kiss I, Logan AG, Nemcsik J, Szabó A, Németh ZK, Szathmári M, Tislér A.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3256-62. PubMed ID: 18450827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.